
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies

LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies
Netramark Holdings expands into phase three programs
Microbix Schedules Release of Results for Q4 Fiscal 2025
Betterlife hires YAFO as adviser in Greater China
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting
PharmaCorp Enters Letter of Intent for the Acquisition of Pharmacy Files in Western Canada
Safe Supply closes $935,000 private placement
NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company
BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital
Safe Supply Announces Closing of Upsized Financing
Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
Innocan files amendment for U.S. public offering
Hemostemix basket protocol pre-IND meeting set for Jan.
Surenano Science closes $1.25-million financing